Oxygenta Pharmaceutical Ltd — Important, 14-07-2026: Company Update

Oxygenta Pharmaceutical has confirmed its adherence to regulations concerning dematerialized shares for the recent quarter. The company reported that all necessary information about shares converted to electronic format was provided to stock exchanges. Its Registrar and Share Transfer Agent also certified that dematerialization requests were processed efficiently, with physical share certificates cancelled and electronic records promptly updated. This update assures investors of accurate and well-maintained shareholder records.